- 1、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
公司基本背景
公司基本背景:
总部在美国,主要生产CR/DR、图像显示装置,以及在机器上集成PACS系统与软件。CR产品因技术更新,目前逐步被DR产品所取代。
Who are we?
X provides advanced Imaging Solutions that help early detection of illness and improve patient outcomes.
We manufacture all our products on site, in an ISO 13485 facility
We are a privately held S Corporation, we have no outside investors
We provide growth opportunities for our employees
We reinvest in Research and Development
We hold patents and internal IP that may lead to key advances in Medical Imaging.
What Are We?
Modality Specific Vendor: CR, DR, PACS, Viewers
IT Company: Vender Neutral PACS/software
Market Specific: Mammography, Ortho, Chiro, Hospital,
Radiology Equipment Provider: New product: Turn key solutions for
X-ray rooms
OEM Manufacturer Custom and private label products
SWOT Analysis
Strengths:
Established CR Manufacturer (1 of 7)
Unique Offerings – iDR, iDR-L, Fusion, ClarityPACS, VertX
Established Software Platforms – Acquisitions/PACS
Product Development- New Direct Conversion materials for DR
Software Development- RIS and Practice Management SW
Software Customization: As needed multiple modality
Established OEM and Dealer Channel: Domestic
Diversified International Sales Channel: Worldwide
Regulatory Approval Process for FDA in place
Marketing Communications: Web presence, known name brand
American Manufacturer
Weaknesses:
Limited distribution in some markets
Too many Products/Not enough marketing muscle
Lack of Residual Income –(film)/parts/service contracts
High Production Cost (Made in California)
Technical Support revenue stream is low:
Limited Direct Sales Force: Need to expand
Limited Corporate Offices: Need to expand
Limited funding for new development: Funded in-house
Opportunities
Established CR and PACS Manufacturer – Entry to the radiology space: Future potential as a DR vendor
Established OEM and Dealer Channel
Rapid Film Conversation: Digital Company, no dependence on film revenue.
New Device Accep
文档评论(0)